Back
Anterix Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
34
ATEX
Anterix
Last Price:
31.53
Seasonality Move:
-4.3%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
40.74
Seasonality Move:
-0.9%
Sell
34
Anterix (ATEX)
is a Sell
Is Anterix a Buy, Sell or Hold?
- The current Anterix [ATEX] share price is $31.25. The Score for ATEX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ATEX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.82
The current trend is relatively stagnant and RARE is experiencing slight buying pressure.
ATEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 46.03 | Sell |
| Chaikin Money Flow: | 163929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.89 - 33.37) | Sell |
| Bollinger Bands (100): | (30.91 - 35.79) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 46.74 | Sell |
| Chaikin Money Flow: | 84619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.82 - 42.02) | Sell |
| Bollinger Bands (100): | (40.86 - 48.8) | Sell |
ATEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.57 | Buy |
| 20-day SMA: | 31.96 | Sell |
| 50-day SMA: | 32.08 | Sell |
| 200-day SMA: | 32.66 | Sell |
| 8-day EMA: | 30.73 | Buy |
| 20-day EMA: | 31.47 | Sell |
| 50-day EMA: | 32.17 | Sell |
| 200-day EMA: | 32.83 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.53 | Buy |
| 20-day SMA: | 40.36 | Sell |
| 50-day SMA: | 41.57 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.71 | Buy |
| 20-day EMA: | 40.38 | Sell |
| 50-day EMA: | 41.84 | Sell |
| 200-day EMA: | 43.38 | Sell |
Anterix Earnings Growth & ATEX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.05 per share, and a decrease next year of $1.58 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.
Anterix Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||